These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 19146410)
1. Discovery of indoline-based, natural-product-like compounds as probes of focal adhesion kinase signaling pathways. Poondra RR; Kumar NN; Bijian K; Prakesch M; Campagna-Slater V; Reayi A; Reddy PT; Choudhry A; Barnes ML; Leek DM; Daroszewska M; Lougheed C; Xu B; Schapira M; Alaoui-Jamali MA; Arya P J Comb Chem; 2009 Mar; 11(2):303-9. PubMed ID: 19146410 [TBL] [Abstract][Full Text] [Related]
2. Building skeletally diverse architectures on the Indoline Scaffold: the discovery of a chemical probe of focal adhesion kinase signaling networks. Prakesch M; Bijian K; Campagna-Slater V; Quevillon S; Joseph R; Wei CQ; Sesmilo E; Reayi A; Poondra RR; Barnes ML; Leek DM; Xu B; Lougheed C; Schapira M; Alaoui-Jamali M; Arya P Bioorg Med Chem; 2008 Nov; 16(21):9596-602. PubMed ID: 18835181 [TBL] [Abstract][Full Text] [Related]
3. Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK). Lu Y; Sun H J Med Chem; 2020 Dec; 63(23):14382-14403. PubMed ID: 33058670 [TBL] [Abstract][Full Text] [Related]
4. Fragment-based discovery of focal adhesion kinase inhibitors. Grädler U; Bomke J; Musil D; Dresing V; Lehmann M; Hölzemann G; Greiner H; Esdar C; Krier M; Heinrich T Bioorg Med Chem Lett; 2013 Oct; 23(19):5401-9. PubMed ID: 23973211 [TBL] [Abstract][Full Text] [Related]
5. Computational-based discovery of FAK FERM domain chemical probes that inhibit HER2-FAK cancer signaling. Stahl E; Nott R; Koessel K; Cance W; Marlowe T Chem Biol Drug Des; 2020 Jun; 95(6):584-599. PubMed ID: 32080977 [TBL] [Abstract][Full Text] [Related]
6. The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells. Serrels A; McLeod K; Canel M; Kinnaird A; Graham K; Frame MC; Brunton VG Int J Cancer; 2012 Jul; 131(2):287-97. PubMed ID: 21823119 [TBL] [Abstract][Full Text] [Related]
8. Novel Small Molecule JP-153 Targets the Src-FAK-Paxillin Signaling Complex to Inhibit VEGF-Induced Retinal Angiogenesis. Toutounchian JJ; Pagadala J; Miller DD; Baudry J; Park F; Chaum E; Morales-Tirado V; Yates CR Mol Pharmacol; 2017 Jan; 91(1):1-13. PubMed ID: 27913654 [TBL] [Abstract][Full Text] [Related]
9. Solution- and solid-phase, modular approaches for obtaining different natural product-like polycyclic architectures from an aminoindoline scaffold for combinatorial chemistry. Reddy PT; Quevillon S; Gan Z; Forbes N; Leek DM; Arya P J Comb Chem; 2006; 8(6):856-71. PubMed ID: 17096575 [TBL] [Abstract][Full Text] [Related]
10. Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. Roberts WG; Ung E; Whalen P; Cooper B; Hulford C; Autry C; Richter D; Emerson E; Lin J; Kath J; Coleman K; Yao L; Martinez-Alsina L; Lorenzen M; Berliner M; Luzzio M; Patel N; Schmitt E; LaGreca S; Jani J; Wessel M; Marr E; Griffor M; Vajdos F Cancer Res; 2008 Mar; 68(6):1935-44. PubMed ID: 18339875 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation, and molecular dynamics (MD) simulation studies of three novel F-18 labeled and focal adhesion kinase (FAK) targeted 5-bromo pyrimidines as radiotracers for tumor. Fang Y; Wang D; Xu X; Liu J; Wu A; Li X; Xue Q; Wang H; Wang H; Zhang H Eur J Med Chem; 2017 Feb; 127():493-508. PubMed ID: 28109944 [TBL] [Abstract][Full Text] [Related]
12. Identification of methyl violet 2B as a novel blocker of focal adhesion kinase signaling pathway in cancer cells. Kim H; Kim ND; Lee J; Han G; Sim T Biochem Biophys Res Commun; 2013 Jul; 437(2):319-24. PubMed ID: 23817042 [TBL] [Abstract][Full Text] [Related]
13. Focal adhesion kinase: exploring Fak structure to gain insight into function. Hall JE; Fu W; Schaller MD Int Rev Cell Mol Biol; 2011; 288():185-225. PubMed ID: 21482413 [TBL] [Abstract][Full Text] [Related]
14. Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy. Pang XJ; Liu XJ; Liu Y; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Song J; Jin CY; Zhang SY Molecules; 2021 Jul; 26(14):. PubMed ID: 34299525 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of Yangzheng Xiaoji on angiogenesis and the role of the focal adhesion kinase pathway. Jiang WG; Ye L; Ji K; Frewer N; Ji J; Mason MD Int J Oncol; 2012 Nov; 41(5):1635-42. PubMed ID: 22971748 [TBL] [Abstract][Full Text] [Related]
16. Stereocontrolled solid-phase synthesis of a 90-membered library of indoline-alkaloid-like polycycles from an enantioenriched aminoindoline scaffold. Gan Z; Reddy PT; Quevillon S; Couve-Bonnaire S; Arya P Angew Chem Int Ed Engl; 2005 Feb; 44(9):1366-8. PubMed ID: 15674986 [No Abstract] [Full Text] [Related]
17. A novel synthetic small molecule YH-306 suppresses colorectal tumour growth and metastasis via FAK pathway. Dai F; Chen Y; Huang L; Wang J; Zhang T; Li J; Tong W; Liu M; Yi Z J Cell Mol Med; 2015 Feb; 19(2):383-95. PubMed ID: 25351103 [TBL] [Abstract][Full Text] [Related]
18. In Silico Screening to Identify Inhibitors of Growth Factor Receptor 2-Focal Adhesion Kinase Interaction for Therapeutic Treatment of Pathological Cardiac Hypertrophy. Mohanty P; Bhatnagar S Assay Drug Dev Technol; 2019; 17(2):58-67. PubMed ID: 30869527 [TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of a real-time activity probe for focal adhesion kinase. Beck JR; Zhou X; Casey GR; Stains CI Anal Chim Acta; 2015 Oct; 897():62-8. PubMed ID: 26515006 [TBL] [Abstract][Full Text] [Related]
20. Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights. Yoon H; Dehart JP; Murphy JM; Lim ST J Histochem Cytochem; 2015 Feb; 63(2):114-28. PubMed ID: 25380750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]